Editas Medicine, Inc. (EDIT)
2.70
+0.05
(+1.89%)
USD |
NASDAQ |
Sep 11, 16:00
2.70
0.00 (0.00%)
After-Hours: 07:46
Editas Medicine Market Cap : 414.53M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 414.53M |
| September 10, 2026 | 406.86M |
| September 09, 2026 | 425.28M |
| September 08, 2026 | 465.20M |
| September 04, 2026 | 495.90M |
| September 03, 2026 | 472.88M |
| September 02, 2026 | 472.88M |
| September 01, 2026 | 471.34M |
| August 31, 2026 | 469.80M |
| August 28, 2026 | 485.16M |
| August 27, 2026 | 506.65M |
| August 26, 2026 | 488.23M |
| August 25, 2026 | 503.58M |
| August 24, 2026 | 460.59M |
| August 21, 2026 | 477.48M |
| August 20, 2026 | 451.38M |
| August 19, 2026 | 498.98M |
| August 18, 2026 | 442.17M |
| August 17, 2026 | 436.03M |
| August 14, 2026 | 432.96M |
| August 13, 2026 | 431.42M |
| August 12, 2026 | 436.03M |
| August 11, 2026 | 452.92M |
| August 10, 2026 | 431.42M |
| August 07, 2026 | 442.17M |
| Date | Value |
|---|---|
| August 06, 2026 | 445.24M |
| August 05, 2026 | 422.21M |
| August 04, 2026 | 425.28M |
| August 03, 2026 | 406.86M |
| July 31, 2026 | 252.50M |
| July 30, 2026 | 263.26M |
| July 29, 2026 | 254.45M |
| July 28, 2026 | 256.41M |
| July 27, 2026 | 262.28M |
| July 24, 2026 | 254.45M |
| July 23, 2026 | 267.18M |
| July 22, 2026 | 272.07M |
| July 21, 2026 | 282.84M |
| July 20, 2026 | 281.86M |
| July 17, 2026 | 291.64M |
| July 16, 2026 | 281.86M |
| July 15, 2026 | 297.52M |
| July 14, 2026 | 309.26M |
| July 13, 2026 | 309.26M |
| July 10, 2026 | 319.05M |
| July 09, 2026 | 322.96M |
| July 08, 2026 | 359.17M |
| July 07, 2026 | 367.00M |
| July 06, 2026 | 357.21M |
| July 02, 2026 | 357.21M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Recursion Pharmaceuticals, Inc. | 1.709B |
| Geron Corp. | 867.33M |
| Halozyme Therapeutics, Inc. | 12.23B |
| Novavax, Inc. | 1.553B |
| AVITA Medical, Inc. | 305.56M |
Market Cap Related Metrics
| PS Ratio | 5.809 |
| Price to Book Value | 3.937 |
| Price | 2.70 |
| Earnings Yield | -27.58% |